Loading
Latest filing published 21 Apr 2025 for NurExone Biologic Inc formerly, EnerSpar Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Oded Orgil on record concern NurExone Biologic Inc. (formerly, EnerSpar Corp.). We count 2 filings; the first trade dates from 15 June 2022 and the latest from 19 April 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 21 April 2025: a share grant, in NurExone Biologic Inc. (formerly, EnerSpar Corp.). This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations